
### [MONDO:0020180](http://purl.obolibrary.org/obo/MONDO_0020180)
**Label:** palpebral piliary tumor

**Subclasses:** [MONDO:0011512](http://purl.obolibrary.org/obo/MONDO_0011512) (Brooke-Spiegler syndrome), [MONDO:0011114](http://purl.obolibrary.org/obo/MONDO_0011114) (familial multiple trichoepithelioma), 

**Corr. equiv. classes:** [Orphanet:79493](http://www.orpha.net/ORDO/Orphanet_79493), [Orphanet:867](http://www.orpha.net/ORDO/Orphanet_867), [OMIM:605041](http://purl.obolibrary.org/obo/OMIM_605041), [OMIM:601606](http://purl.obolibrary.org/obo/OMIM_601606), 

**Class expressions from DL-Learner:**

- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0200034](http://purl.obolibrary.org/obo/HP_0200034) (Papule) 62.50%
- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0100585](http://purl.obolibrary.org/obo/HP_0100585) (Telangiectasia of the skin) 62.50%
- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0003581](http://purl.obolibrary.org/obo/HP_0003581) (Adult onset) 62.50%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) 62.50%
- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0200034](http://purl.obolibrary.org/obo/HP_0200034) (Papule) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 62.50%
- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0100585](http://purl.obolibrary.org/obo/HP_0100585) (Telangiectasia of the skin) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 62.50%
- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0100585](http://purl.obolibrary.org/obo/HP_0100585) (Telangiectasia of the skin) and [HP:0200034](http://purl.obolibrary.org/obo/HP_0200034) (Papule) 62.50%
- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0100585](http://purl.obolibrary.org/obo/HP_0100585) (Telangiectasia of the skin) 62.50%
- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 62.50%
- [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 62.50%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 62.50%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 62.50%
- [HP:0001482](http://purl.obolibrary.org/obo/HP_0001482) (Subcutaneous nodule) and [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0200034](http://purl.obolibrary.org/obo/HP_0200034) (Papule) 62.50%
- [HP:0001482](http://purl.obolibrary.org/obo/HP_0001482) (Subcutaneous nodule) and [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0100585](http://purl.obolibrary.org/obo/HP_0100585) (Telangiectasia of the skin) 62.50%
- [HP:0001482](http://purl.obolibrary.org/obo/HP_0001482) (Subcutaneous nodule) and [HP:0002671](http://purl.obolibrary.org/obo/HP_0002671) (Basal cell carcinoma) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 62.50%


